胎龄与危重先天性心脏病婴儿结局
CCHD发生率在29-31周最高(0.9%),39-42周最低(0.2%)。CCHD婴儿在34-36周出生较37-38周死亡或疾病风险更高(调整ARD 9.1%,95%CI 5.5%-12.7%),37-38周较39-42周风险更高(调整ARD 3.2%,95%CI 1.6%-4.9%)。
要点
- CCHD婴儿新生儿疾病或死亡风险随胎龄降低而升高。
- 34-36周CCHD婴儿死亡或疾病风险比37-38周高9.1%。
- 37-38周CCHD婴儿死亡或疾病风险比39-42周高3.2%。
核心结论
- CCHD婴儿新生儿疾病风险高,且所有胎龄组均高于39-42周出生者。
研究设计与样本
- 队列研究,链接出生证明、婴儿出院、再入院和死亡记录,纳入2005-2012年22-42周无染色体异常的活产婴儿共2 988 925例。
主要发现
- 共识别6903例CCHD婴儿,占2 968 566例的0.23%。
- CCHD发生率在29-31周最高(0.9%),39-42周最低(0.2%)。
- CCHD婴儿合并新生儿疾病或死亡率在<29周为82.8%,39-42周降至10.9%;无CCHD婴儿分别为57.9%和0.1%。
关键数值与推荐
- CCHD婴儿34-36周出生较37-38周死亡或疾病风险更高,调整ARD 9.1%(95%CI 5.5%-12.7%)。
- CCHD婴儿37-38周出生较39-42周死亡或疾病风险更高,调整ARD 3.2%(95%CI 1.6%-4.9%)。
临床怎么用
- 照护CCHD婴儿时应考虑其胎龄相关的显著新生儿疾病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: It is unknown how gestational age (GA) impacts neonatal morbidities in infants with critical congenital heart disease (CCHD). We aim to quantify GA-specific mortality and neonatal morbidity in infants with CCHD. METHODS: Cohort study using a database linking birth certificate, infant hospital discharge, readmission, and death records, including infants 22 to 42 weeks' GA without chromosomal anomalies (2005-2012, 2 988 925 live births). The International Classification of Diseases, Ninth Revision diagnostic and procedure codes were used to define CCHD and neonatal morbidities (intraventricular hemorrhage, retinopathy, periventricular leukomalacia, chronic lung disease, necrotizing enterocolitis). Adjusted absolute risk differences (ARDs) with 95% confidence intervals (CIs) were calculated. RESULTS: We identified 6903 out of 2 968 566 (0.23%) infants with CCHD. The incidence of CCHD was highest at 29 to 31 weeks' GA (0.9%) and lowest at 39 to 42 weeks (0.2%). Combined neonatal morbidity or mortality in infants with and without CCHD was 82.8% and 57.9% at <29 weeks and declined to 10.9% and 0.1% at 39 to 42 weeks' GA. In infants with CCHD, being born at 34 to 36 weeks was associated with a higher risk of death or morbidity than being born at 37 to 38 weeks (adjusted ARD 9.1%, 95% CI 5.5% to 12.7%), and being born at 37 to 38 weeks was associated with a higher risk of death or morbidity than 39 to 42 weeks (adjusted ARD 3.2%, 95% CI 1.6% to 4.9%). CONCLUSIONS: Infants born with CCHD are at high risk of neonatal morbidity. Morbidity remains increased across all GA groups in comparison with infants born at 39 to 42 weeks. This substantial risk of neonatal morbidity is important to consider when caring for this patient population.
引用
- Steurer MA, Baer RJ, Keller RL, et al. Gestational Age and Outcomes in Critical Congenital Heart Disease. Pediatrics. 2017. PMID: 28885171. doi:10.1542/peds.2017-0999
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。